Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Nicolas Goldaracena"'
Publikováno v:
Frontiers in Transplantation, Vol 2 (2023)
IntroductionFollowing procurement, the liver graft is exposed to an ischemic period that triggers several pathophysiologic changes in response to oxygen deprivation. Therefore, the goal during organ preservation is to attenuate such response and prov
Externí odkaz:
https://doaj.org/article/02854043b0b844b6b4ef6299975e47e0
Autor:
Paola A. Vargas, MD, Haowei Wang, MD, Christina Dalzell, BS, Curtis Argo, MD, Zachary Henry, MD, Feng Su, MD, Matthew J. Stotts, MD, Patrick Northup, MD, Jose Oberholzer, MD, Shawn Pelletier, MD, Nicolas Goldaracena, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 5, p e1315 (2022)
Background. The use of pediatric grafts for liver transplantation (LT) into adult recipients is rare, and reported outcomes are conflicting. The aim of this study is to evaluate the outcomes in adult recipients following LT with grafts from deceased
Externí odkaz:
https://doaj.org/article/639a914aa7d248b7926318821e60ae54
Autor:
Christina Dalzell, Paola A. Vargas, Kyle Soltys, Frank Di Paola, George Mazariegos, Nicolas Goldaracena
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
In pediatric patients with extrahepatic portal vein obstruction and complications of portal hypertension, but with normal liver function, a meso-Rex bypass (MRB) connecting the superior mesenteric vein to the intrahepatic left portal is the favored s
Externí odkaz:
https://doaj.org/article/c0ee52215415486381e17e90398013dc
Autor:
Paola A. Vargas, MD, J. Michael Cullen, MD, Curtis Argo, MD, Zachary Henry, MD, Matthew J. Stotts, MD, Nicolas Intagliata, MD, Patrick Northup, MD, Jose Oberholzer, MD, Shawn Pelletier, MD, Nicolas Goldaracena, MD
Publikováno v:
Transplantation Direct, Vol 7, Iss 10, p e770 (2021)
Background. There are limited data on liver transplant (LT) outcomes with grafts from super obese donors. The present study aims to evaluate a unique cohort of recipients following LT using grafts from donors with body mass index (BMI) ≥50. Methods
Externí odkaz:
https://doaj.org/article/0e0d74dde0e44827919aac7e196cec0f
Autor:
Sarah Shan, BA, Paola Vargas, MD, Jakob Durden, BA, Tara Seay, RN, Tessa Williams, RN, Emily Lyster, SW, Anita Sites, NP, Patrick Northup, MD, Shawn Pelletier, MD, Jose Oberholzer, MD, Curtis Argo, MD, Nicolas Goldaracena, MD
Publikováno v:
Transplantation Direct, Vol 7, Iss 8, p e726 (2021)
Background. Anonymous living liver donations (ALLDs) raise ethical concerns regarding the donors’ motivations. Thus, ALLDs are not as widely accepted as directed donations from friends and family. Literature on ALLDs is limited. Understanding this
Externí odkaz:
https://doaj.org/article/8ff62659061e4004a9100447e7b7e7b7
Autor:
John T. Rose, BS, Paola Vargas, MD, Tara Seay, RN, Arthur J. Pesch, MD, Tessa Williams, RN, Anita Sites, NP, Zachary Henry, MD, Patrick G. Northup, MD, Shawn J. Pelletier, MD, Jose Oberholzer, MD, Curtis K. Argo, MD, Nicolas Goldaracena, MD
Publikováno v:
Transplantation Direct, Vol 7, Iss 6, p e702 (2021)
Background. Living donor liver transplantation offers an attractive option to reduce the waitlist mortality. However, in recent years, the rising prevalence of obesity and nonalcoholic fatty liver disease has posed a serious threat to the donor pool
Externí odkaz:
https://doaj.org/article/6ed2c8131bcb4fd9a705aa5a2f189885
Autor:
Andrew S. Barbas, MD, Jordan Levy, MD, Michael S. Mulvihill, MD, Nicolas Goldaracena, MD, Martin J. Dib, MD, David P. Al-Adra, MD, PhD, Mark S. Cattral, MD, Anand Ghanekar, MD, PhD, Paul D. Greig, MD, David R. Grant, MD, Gonzalo Sapisochin, MD, Markus Selzner, MD, Stuart A. McCluskey, MD, Ian D. McGilvray, MD, PhD
Publikováno v:
Transplantation Direct, Vol 4, Iss 5, p e348 (2018)
Background. The use of venovenous bypass in liver transplantation has declined over time. Few studies have examined the impact of surgical approach in cases performed exclusively without venovenous bypass. We hypothesized that advances in liver trans
Externí odkaz:
https://doaj.org/article/99bb2c8660984bc5a571defa207eab60
Autor:
Juan Echeverri, MD, Nicolas Goldaracena, MD, Akhil Kant Singh, MD, Gonzalo Sapisochin, MD, Nazia Selzner, MD, Mark S. Cattral, MD, Paul D. Greig, MD, Les Lilly, MD, Ian D. McGilvray, MD, Gary A. Levy, MD, Anand Ghanekar, MD, Eberhard L. Renner, MD, David R. Grant, MD, Stuart A. McCluskey, MD, Markus Selzner, MD
Publikováno v:
Transplantation Direct, Vol 3, Iss 10, p e213 (2017)
Background. We evaluated patient characteristics of live donor liver transplant (LDLT) recipients undergoing a fast-track protocol without intensive care unit (ICU) admission versus LDLT patients receiving posttransplant ICU care. Methods. Of the 1
Externí odkaz:
https://doaj.org/article/b5f154b7775d4a4a998236f9c1110df6
Autor:
Andrew S. Barbas, MD, David P. Al-Adra, MD, PhD, Nicolas Goldaracena, MD, Martin J. Dib, MD, Markus Selzner, MD, Gonzalo Sapisochin, MD, Mark S. Cattral, MD, Ian D. McGilvray, MD, PhD
Publikováno v:
Transplantation Direct, Vol 3, Iss 9, p e203 (2017)
Abstract. Although the primary indication for pancreas transplantation is type I diabetes, a small number of patients requires pancreas transplantation to manage combined endocrine and exocrine insufficiency that develops after extensive native pancr
Externí odkaz:
https://doaj.org/article/c64bdac8442a4a8f8c5087c6373beaf4
Autor:
Vinzent Spetzler, MD, Nicolas Goldaracena, MD, Johann Moritz Kaths, MD, Max Marquez, MD, Markus Selzner, MD, Nazia Selzner, MD, PhD
Publikováno v:
Transplantation Direct, Vol 3, Iss 8, p e187 (2017)
Background. The cytoprotective effects of hemeoxygenase-1 and its product biliverdin/bilirubin are widely acknowledged in experimental transplant medicine. However, its potentially beneficial effect during organ reperfusion is not established. Method
Externí odkaz:
https://doaj.org/article/57729e6b681149368d2a150bb8e7f7d3